EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody

Iuliia Pilipenko, Katja Stenberg, Jooseppi Puranen, Elisa Toropainen, Iida Määttä, Michael Jeltsch, Suvi Jauhiainen, Tiina Nieminen, Johanna P Laakkonen, Seppo Ylä-Herttuala, Elena Scurti, Tapani Viitala und 2 weitere

Acta Biomaterialia · 2026-08 · 219 · 167-179

DOI: 10.1016/j.actbio.2026.06.061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-08. Verfasst von Iuliia Pilipenko und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immunoglobulin Fab Fragments, Hydrogels, Temperature. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strategic Research Council, Sigrid Jusélius Foundation, Research Council for Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic antibodies are a cornerstone of modern medicine, providing targeted and effective treatments for a wide range of diseases. Antibody delivery, however, has long been recognized as a major bottleneck for safety and efficacy. We developed a hyaluronic acid-poloxamer 407-calcium (HAP-Ca2+) thermoresponsive hydrogel for the controlled, long-term delivery of a full-length human monoclonal antibody (mAb) and an antibody fragment (Fab). The hydrogel enabled sustained, biphasic release of the mAb without initial burst (∼60% released over 25 days, followed by 20% over 35 days), while the Fab showed a modest burst (∼15% on day 1) and gradual release over two months. Both antibodies retained thermal stability and structural integrity, confirmed by nanoscale differential scanning fluorometry (nanoDSF) and circular dichroism (CD). Microscale thermophoresis (MST) showed maintained Fab binding over one month (KD ≈ 40 nM), while mAb EC50 increased from 0.108 nM to 0.338 nM. In vitro assays demonstrated biological activity for up to three weeks following hydrogel release. In vivo intravitreal administration in rabbits demonstrated that the hydrogel prolonged the vitreal half-life of mAb compared to PBS (7.0 ± 1.5 vs 5.1 ± 0.9 days), extending the time above estimated reference concentrations by approximately 5-11 days. Our results show that the HAP-Ca2+ thermoresponsive hydrogel can deliver Fab and mAb in a controlled, long-lasting manner while preserving their structure and activity, making it a strong candidate for sustained antibody delivery. More broadly, thermoresponsive hydrogels like this are emerging as powerful tools to enhance the safety and efficacy of antibody therapies. STATEMENT OF SIGNIFICANCE: Antibodies are among the most powerful medicines but delivering them safely and steadily remains a challenge. We designed a smart hydrogel that gradually releases both a full-length antibody and a smaller antibody fragment, avoiding sudden bursts that can cause side effects. Importantly, the antibodies retain their structure and activity for weeks after release. This represents an important step toward achieving controlled, long-term delivery for these complex molecules. More broadly, our study suggests that temperature-responsive hydrogels could serve as promising antibody delivery systems, an approach with the potential to make future therapies safer, longer-lasting, and more practical for real-world patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalImmunoglobulin Fab FragmentsHydrogelsTemperatureDrug Delivery SystemsHumansAnimalsPoloxamerHyaluronic AcidRabbitsCalciumDelayed-Action Preparations

Stichwörter der Autor:innen

Antibody binding activityAntibody deliveryAntibody structural integrityThermoresponsive hydrogelmAb and Fab sustained release

Substanzen

Antibodies, MonoclonalImmunoglobulin Fab FragmentsHydrogelsPoloxamerHyaluronic AcidCalciumDelayed-Action Preparations

Autor:innen und Institutionen

  • School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.
  • Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014, Helsinki, Finland; Wihuri Research Institute, Haartmaninkatu 8, 00290, Helsinki, Finland; Faculty of Medicine, University of Helsinki, P.O. Box 63, 00014,…
  • A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.
  • Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014, Helsinki, Finland.
  • Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014, Helsinki, Finland; Faculty of Science and Engineering, Åbo Akademi University, Artillerigatan 6B, 20520, Åbo, Finland.
  • School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. Electronic address: astrid.subrizi@uef.fi.

Förderung

  • Strategic Research Council
  • Sigrid Jusélius Foundation
  • Research Council for Health

Zitieren

APA

Pilipenko, I., Stenberg, K., Puranen, J., Toropainen, E., Määttä, I., Jeltsch, M., Jauhiainen, S., Nieminen, T., Laakkonen, J. P., Ylä-Herttuala, S., Scurti, E., Viitala, T., Urtti, A., & Subrizi, A. (2026). Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody. Acta Biomaterialia, 219, 167-179. https://doi.org/10.1016/j.actbio.2026.06.061

Vancouver

Pilipenko I, Stenberg K, Puranen J, Toropainen E, Määttä I, Jeltsch M, et al. Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody. Acta Biomaterialia. 2026;219:167-179. doi:10.1016/j.actbio.2026.06.061

BibTeX
@article{Pilipenko2026,
  author = {Pilipenko, Iuliia and Stenberg, Katja and Puranen, Jooseppi and Toropainen, Elisa and Määttä, Iida and Jeltsch, Michael and Jauhiainen, Suvi and Nieminen, Tiina and Laakkonen, Johanna P and Ylä-Herttuala, Seppo and Scurti, Elena and Viitala, Tapani and Urtti, Arto and Subrizi, Astrid},
  title = {Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {219},
  pages = {167--179},
  doi = {10.1016/j.actbio.2026.06.061}
}
Kostenlos starten →